Latest NewsNov 4, 2024HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases All Filter By: Year2024202320222021202020192018201720162015Oct 15, 2018HiFiBiO Therapeutics Acquires H-Immune TherapeuticsOct 2, 2018Research Collaboration to Develop Technology for the Treatment of CancerJul 30, 2018HiFiBiO Therapeutics Signs Multi-Target Antibody Discovery Agreement with TakedaMay 16, 2018HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune DisordersOct 12, 2017HiFiBiO and collaborators publish single-cell microfluidics work in Nature Biotechnology< 1 … 12 13 14 15 16 17 >
